Medicare Enrolled

Dr. Laura Mason, M.D.

Neurology · Hendersonville, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
50 DOCTORS DR, Hendersonville, NC 28792
8286514089
In practice since 2007 (19 years)
NPI: 1831392828 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mason from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mason? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mason

Dr. Laura Mason is a neurology specialist in Hendersonville, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mason performed 801 Medicare services across 713 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mason received a total of $7,386 from 59 pharmaceutical and/or device companies across 539 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mason is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 25% volume in NC $7,386 industry payments

Medicare Practice Summary

Medicare Utilization ↗
801
Medicare services
Top 25% in NC for neurology
713
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~42 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
191 $46 $211
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
137 $90 $425
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
121 $65 $312
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
96 $26 $113
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
63 $60 $259
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
50 $82 $412
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
49 $34 $135
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
40 $57 $234
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
21 $100 $387
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
20 $43 $169
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
13 $14 $54
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,386
Total received (2018-2024)
Avg $1,055/year across 7 years
Top 26% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
539
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,278 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$109 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,282
2023
$1,475
2022
$735
2021
$376
2020
$540
2019
$1,195
2018
$783

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$357
Teva Pharmaceuticals USA, Inc.
$353
MDD US Operations, LLC
$341
Novartis Pharmaceuticals Corporation
$247
Biogen, Inc.
$237
TG Therapeutics, Inc.
$164
ARGENX US, INC.
$123
PFIZER INC.
$94
Alexion Pharmaceuticals, Inc.
$84
AstraZeneca Pharmaceuticals LP
$49
Celgene Corporation
$48
Sumitomo Pharma America, Inc.
$41
Amneal Pharmaceuticals LLC
$29
Lilly USA, LLC
$28
JAZZ PHARMACEUTICALS INC.
$23
SK Life Science, Inc.
$19
HARMONY BIOSCIENCES LLC
$17
Amgen Inc.
$15
Genentech USA, Inc.
$13
Top 3 companies account for 46.1% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$1,000
ABBVIE INC.
$670
Supernus Pharmaceuticals, Inc.
$617
Novartis Pharmaceuticals Corporation
$576
MDD US Operations, LLC
$476
Amgen Inc.
$475
Biogen, Inc.
$384
Alexion Pharmaceuticals, Inc.
$245
Amneal Pharmaceuticals LLC
$219
Lilly USA, LLC
$199
PFIZER INC.
$190
US WorldMeds, LLC
$190
ARGENX US, INC.
$174
TG Therapeutics, Inc.
$164
Celgene Corporation
$126
E.R. Squibb & Sons, L.L.C.
$125
GENZYME CORPORATION
$118
Zyla Life Sciences
$113
Bausch Health US, LLC
$104
Eisai Inc.
$97
Avanir Pharmaceuticals, Inc.
$84
Janssen Pharmaceuticals, Inc
$81
Sunovion Pharmaceuticals Inc.
$60
Genentech USA, Inc.
$51
Adamas Pharmaceuticals, Inc.
$50
AstraZeneca Pharmaceuticals LP
$49
Biohaven Pharmaceuticals, Inc.
$48
Nevro Corp.
$45
IMPEL PHARMACEUTICALS INC.
$42
Sumitomo Pharma America, Inc.
$41
Abbott Laboratories
$39
AbbVie Inc.
$38
Mitsubishi Tanabe Pharma America, Inc.
$36
Lundbeck LLC
$30
TG THERAPEUTICS, INC.
$30
Grifols USA, LLC
$27
EMD Serono, Inc.
$24
JAZZ PHARMACEUTICALS INC.
$23
GE HEALTHCARE
$22
Banner Life Sciences, LLC
$22
Neurocrine Biosciences, Inc.
$20
LivaNova USA, Inc.
$20
SK Life Science, Inc.
$19
ACADIA Pharmaceuticals Inc
$17
HARMONY BIOSCIENCES LLC
$17
Cala Health, Inc.
$16
Upsher-Smith Laboratories LLC
$16
Greenwich Biosciences, Inc.
$16
EISAI INC.
$15
Almatica Pharma LLC
$15
Allergan Inc.
$14
Allergan, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
MITSUBISHI TANABE PHARMA AMERICA, INC.
$13
Assertio Therapeutics, Inc.
$13
UPSHER-SMITH LABORATORIES LLC
$11
Impax Laboratories, Inc.
$11
UCB, Inc.
$11
Metacel Pharmaceuticals LLC
$10
Top 3 companies account for 31.0% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · CALA TRIO · CAMBIA · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · LYRICA · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · OCREVUS · OXTELLAR XR · Ocrevus Zunovo · Ozobax · POMPE - DISEASE · PROCLAIM · Ponvory · QULIPTA · RADICAVA · RYTARY · Radicava · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · Senza · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · XADAGO · Xadago · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Hendersonville?
Compare neurologists in the Hendersonville area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
30
Per 100K population
25.6
County median income
$67,623
Nearest hospital
ADVENTHEALTH HENDERSONVILLE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mason is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NC), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mason experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mason performed 191 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mason receive payments from pharmaceutical companies?
Yes. Dr. Mason received a total of $7,386 from 59 companies across 539 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mason's costs compare to other neurologists in Hendersonville?
Dr. Mason's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mason) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →